Lab
Sanford Medical Center
Sanford Medical Center was paid $18.03M by Medicaid between Jan 2018 and Dec 2024, across 225 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 15% of everything it billed.
33Billing provider infoSANFORD MEDICAL CENTER
SIOUX FALLS, SD 57104
SIOUX FALLS, SD 57104
33aNPI1841242542assigned 05/17/2006
33bProvider typeClinical Medical Laboratory
28Total paid$18.03M
24GClaims938,859
24DCodes billed225
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in South Dakota
Rank by total paid#1 of 12
Median peer was paid$312K
This provider vs. median58×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORRISON, TONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,671 | $1.63M | |
| 2019 | 94,897 | $1.61M | |
| 2020 | 82,094 | $2.31M | |
| 2021 | 146,966 | $3.07M | |
| 2022 | 157,501 | $3.01M | |
| 2023 | 173,074 | $2.96M | |
| 2024incomplete | 195,656 | $3.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 15% | 36,533 | 33,769 | $2.76M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.7% | 29,615 | 28,017 | $1.02M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.3% | 24,157 | 22,654 | $776K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.3% | 24,187 | 22,671 | $776K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.1% | 5,963 | 5,751 | $738K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.0% | 1,424 | 1,382 | $546K |
| 87507 | 3.0% | 1,372 | 1,296 | $534K | |
| 36415 | Collection of venous blood by venipuncture | 2.9% | 115,807 | 99,995 | $528K |
| 86003 | 2.8% | 7,345 | 5,548 | $507K | |
| 0240U | 2.7% | 4,904 | 3,930 | $478K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 4,336 | 4,148 | $424K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 55,710 | 49,624 | $410K |
213 more codes
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.9% | 10,662 | $350K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 22,217 | $337K |
| 80053 | Comprehensive metabolic panel | 1.8% | 34,849 | $332K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.7% | 13,836 | $304K |
| 80050 | General health panel | 1.6% | 5,217 | $282K |
| 80061 | Lipid panel | 1.4% | 20,450 | $248K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 6,801 | $243K |
| 86480 | 1.3% | 4,219 | $237K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.3% | 699 | $231K |
| 87631 | 1.3% | 1,498 | $229K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 4,953 | $228K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.2% | 8,551 | $220K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 9,199 | $206K |
| 87150 | 1.1% | 5,445 | $198K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 25,219 | $193K |
| 86780 | <1% | 13,985 | $177K | |
| 87522 | Neg quan hep c or qual rna | <1% | 3,239 | $150K |
| 84439 | <1% | 18,493 | $143K | |
| 86762 | <1% | 10,058 | $135K | |
| 86803 | <1% | 10,220 | $133K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 14,635 | $126K |
| 87077 | <1% | 14,353 | $125K | |
| 82728 | <1% | 9,470 | $118K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,533 | $109K |
| 87186 | <1% | 10,964 | $98K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12,049 | $93K |
| 85027 | <1% | 14,879 | $91K | |
| 83970 | <1% | 2,212 | $83K | |
| 83550 | <1% | 10,732 | $83K | |
| 87340 | <1% | 8,450 | $82K | |
| 87070 | <1% | 9,322 | $79K | |
| 86850 | <1% | 5,577 | $74K | |
| 82785 | <1% | 4,772 | $73K | |
| 86235 | <1% | 1,056 | $71K | |
| 82607 | <1% | 5,234 | $71K | |
| 87536 | <1% | 841 | $69K | |
| 87634 | <1% | 1,117 | $69K | |
| 83540 | <1% | 11,218 | $65K | |
| 82784 | <1% | 5,604 | $62K | |
| 86364 | <1% | 5,619 | $62K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 901 | $62K |
| 84702 | <1% | 4,238 | $59K | |
| 83516 | <1% | 3,731 | $59K | |
| 81001 | <1% | 17,918 | $56K | |
| 83013 | <1% | 780 | $53K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 691 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,430 | $49K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 746 | $49K |
| 87210 | <1% | 9,024 | $47K | |
| 86255 | <1% | 4,045 | $47K | |
| 81025 | <1% | 5,858 | $42K | |
| 86038 | <1% | 3,468 | $41K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,418 | $40K |
| 83880 | <1% | 1,147 | $39K | |
| 82570 | <1% | 7,755 | $38K | |
| 84146 | <1% | 2,109 | $38K | |
| 87529 | <1% | 592 | $36K | |
| 80047 | <1% | 2,858 | $35K | |
| 80081 | <1% | 384 | $33K | |
| 86140 | <1% | 6,962 | $33K | |
| 36416 | <1% | 17,832 | $30K | |
| 82746 | <1% | 2,115 | $28K | |
| 86696 | <1% | 1,725 | $28K | |
| 80076 | <1% | 3,575 | $28K | |
| 86376 | <1% | 2,056 | $28K | |
| 82950 | <1% | 5,570 | $28K | |
| 83735 | <1% | 4,244 | $26K | |
| 84481 | <1% | 1,699 | $26K | |
| 83001 | <1% | 1,408 | $24K | |
| 86665 | <1% | 841 | $23K | |
| 87486 | <1% | 610 | $23K | |
| 87581 | <1% | 609 | $23K | |
| 84403 | <1% | 1,044 | $23K | |
| 87902 | <1% | 45 | $23K | |
| 86706 | <1% | 2,227 | $22K | |
| 86481 | <1% | 276 | $22K | |
| 86200 | <1% | 1,755 | $21K | |
| 86695 | <1% | 1,713 | $20K | |
| 85004 | <1% | 2,764 | $20K | |
| 83690 | <1% | 2,930 | $20K | |
| 80164 | <1% | 1,504 | $19K | |
| 83993 | <1% | 1,036 | $19K | |
| 81003 | <1% | 8,732 | $19K | |
| 86258 | <1% | 1,099 | $18K | |
| 80069 | <1% | 2,266 | $18K | |
| 85610 | <1% | 4,734 | $18K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 613 | $18K |
| 82247 | <1% | 3,587 | $18K | |
| 87338 | <1% | 1,414 | $18K | |
| 84156 | <1% | 4,899 | $17K | |
| 86147 | <1% | 391 | $17K | |
| 86146 | <1% | 409 | $17K | |
| 82043 | <1% | 3,018 | $17K | |
| 82670 | <1% | 638 | $15K | |
| 86900 | <1% | 5,213 | $15K | |
| 86901 | <1% | 5,166 | $15K | |
| 86704 | <1% | 1,399 | $15K | |
| 85018 | <1% | 6,101 | $15K | |
| 86160 | <1% | 791 | $15K | |
| 86592 | <1% | 3,059 | $15K | |
| 84460 | <1% | 2,736 | $14K | |
| 84100 | <1% | 3,080 | $14K | |
| 82565 | <1% | 2,772 | $14K | |
| 87046 | <1% | 783 | $14K | |
| 86225 | <1% | 1,075 | $14K | |
| 84450 | <1% | 2,617 | $13K | |
| 0352U | <1% | 384 | $13K | |
| 80074 | <1% | 294 | $12K | |
| 84153 | <1% | 755 | $12K | |
| 87147 | <1% | 1,825 | $12K | |
| 86769 | <1% | 351 | $11K | |
| 82274 | <1% | 845 | $11K | |
| 86708 | <1% | 812 | $11K | |
| 82951 | <1% | 821 | $11K | |
| 83002 | <1% | 622 | $10K | |
| 80197 | <1% | 836 | $10K | |
| 86308 | <1% | 1,884 | $10K | |
| 82397 | <1% | 395 | $10K | |
| 87506 | <1% | 41 | $9K | |
| 86039 | <1% | 874 | $9K | |
| 83525 | <1% | 837 | $9K | |
| 85046 | <1% | 1,653 | $9K | |
| 85652 | <1% | 3,272 | $8K | |
| 85048 | <1% | 2,946 | $8K | |
| 87493 | <1% | 161 | $8K | |
| 85007 | <1% | 2,217 | $8K | |
| 87660 | <1% | 460 | $8K | |
| 87480 | <1% | 462 | $8K | |
| 86787 | <1% | 692 | $8K | |
| 87510 | <1% | 464 | $8K | |
| 82533 | <1% | 471 | $7K | |
| 86800 | <1% | 536 | $7K | |
| 86618 | <1% | 441 | $7K | |
| 84144 | <1% | 424 | $7K | |
| 82248 | <1% | 1,439 | $7K | |
| 82947 | <1% | 1,751 | $7K | |
| 82150 | <1% | 1,090 | $7K | |
| 82550 | <1% | 1,079 | $7K | |
| 84550 | <1% | 1,521 | $7K | |
| 80177 | <1% | 577 | $6K | |
| 85651 | <1% | 1,483 | $6K | |
| 80305 | <1% | 596 | $6K | |
| 86645 | <1% | 365 | $6K | |
| 87045 | <1% | 672 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 113 | $5K |
| 82105 | <1% | 354 | $5K | |
| 86008 | <1% | 93 | $5K | |
| 84480 | <1% | 374 | $5K | |
| 82627 | <1% | 246 | $5K | |
| 86644 | <1% | 319 | $4K | |
| 85730 | <1% | 805 | $4K | |
| 87481 | <1% | 98 | $4K | |
| 84703 | <1% | 587 | $4K | |
| 83615 | <1% | 628 | $4K | |
| 82977 | <1% | 512 | $3K | |
| 87040 | <1% | 277 | $3K | |
| 83521 | <1% | 104 | $3K | |
| 82390 | <1% | 298 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 32 | $3K |
| 82952 | <1% | 821 | $3K | |
| 86036 | <1% | 240 | $3K | |
| 82140 | <1% | 199 | $3K | |
| 86431 | <1% | 506 | $3K | |
| 84681 | <1% | 130 | $2K | |
| 86430 | <1% | 465 | $2K | |
| 86231 | <1% | 201 | $2K | |
| 80306 | <1% | 138 | $2K | |
| 86738 | <1% | 102 | $2K | |
| 87653 | <1% | 35 | $2K | |
| 87329 | <1% | 122 | $1K | |
| 81418 | <1% | 14 | $1K | |
| 87328 | <1% | 92 | $1K | |
| 80178 | <1% | 228 | $1K | |
| 87427 | <1% | 112 | $1K | |
| 86709 | <1% | 108 | $1K | |
| 87209 | <1% | 63 | $976.30 | |
| 84165 | <1% | 156 | $975.47 | |
| 86593 | <1% | 232 | $940.16 | |
| 83655 | <1% | 73 | $928.72 | |
| 80320 | <1% | 39 | $921.60 | |
| 87205 | <1% | 260 | $920.80 | |
| 80349 | <1% | 53 | $891.60 | |
| 80345 | <1% | 39 | $787.20 | |
| 81015 | <1% | 260 | $784.91 | |
| 86788 | <1% | 40 | $659.18 | |
| 87088 | <1% | 81 | $596.38 | |
| 87075 | <1% | 69 | $562.96 | |
| 87517 | <1% | 13 | $512.35 | |
| 87177 | <1% | 63 | $483.28 | |
| 85379 | <1% | 46 | $427.42 | |
| 86664 | <1% | 27 | $414.92 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 15 | $385.85 |
| 84520 | <1% | 74 | $370.77 | |
| 83605 | <1% | 33 | $367.44 | |
| 87280 | <1% | 20 | $354.60 | |
| 87275 | <1% | 20 | $354.60 | |
| 87279 | <1% | 20 | $354.60 | |
| 87260 | <1% | 20 | $354.60 | |
| 87276 | <1% | 20 | $348.60 | |
| 84145 | <1% | 12 | $317.07 | |
| 84484 | <1% | 28 | $311.13 | |
| 87299 | <1% | 14 | $246.40 | |
| 82310 | <1% | 46 | $239.79 | |
| 82340 | <1% | 41 | $194.82 | |
| 85014 | <1% | 56 | $176.87 | |
| 82044 | <1% | 30 | $169.16 | |
| 87220 | <1% | 44 | $153.51 | |
| 84132 | <1% | 33 | $124.18 | |
| 85660 | <1% | 19 | $84.15 | |
| 87081 | <1% | 12 | $70.40 | |
| 84300 | <1% | 13 | $60.57 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 13 | $18.95 |
| 0097U | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRISON, TONY (VICE PRESIDENT, REVENUE CYCLE)
Parent organizationSANFORD MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | $50.18M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $47.45M |
| Sanford Bismarck | Bismarck, ND | $43.96M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $27.11M |
| Sanford Medical Center | Sioux Falls, SD | $24.40M |
| FM Ambulance Service, INC | Fargo, ND | $23.80M |
| Sanford Health Network | Worthington, MN | $7.58M |
| Sanford Clinic | Sioux Falls, SD | $6.04M |
| Sanford Clinic | Sioux Falls, SD | $5.45M |
| Sanford Healthcare Accessories, LLC | Fargo, ND | $4.79M |
| Sanford Health Network North | Thief River Falls, MN | $3.28M |
| Sanford Clinic | Sioux Falls, SD | $2.96M |
| Sanford Health Network | Jackson, MN | $2.81M |
| Sanford Clinic | Watertown, SD | $2.02M |
| Black Hills Orthopedic & Spine Center, INC. | Rapid City, SD | $1.71M |
| Sanford Health Network | Chamberlain, SD | $1.47M |
| Sanford Health Network | Vermillion, SD | $1.31M |
| Sanford Health Network | Luverne, MN | $1.27M |
| Sanford Medical Center Fargo | Pelican Rapids, MN | $1.01M |
| Sanford Medical Center Fargo | Mahnomen, MN | $994K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.